TY - JOUR
T1 - Acute gastrointestinal symptoms associated with oil spill exposures among U.S. coast guard responders to the Deepwater Horizon oil spill
AU - Anderson, Craig
AU - Krishnamurthy, Jayasree
AU - McAdam, Jordan
AU - Denic-Roberts, Hristina
AU - Priest, Ellie
AU - Thomas, Dana
AU - Engel, Lawrence S.
AU - Rusiecki, Jennifer
N1 - Published by Elsevier Inc.
PY - 2024/1
Y1 - 2024/1
N2 - Purpose: Research investigating gastrointestinal (GI) symptoms from oil spill-related exposures is sparse. We evaluated prevalent GI symptoms among U.S. Coast Guard responders deployed to the Deepwater Horizon oil spill cleanup. Methods: Crude oil (via skin contact, inhalation, or ingestion routes), combined crude oil/oil dispersant exposures, other deployment exposures, deployment characteristics, demographics, and acute GI symptoms during deployment (i.e., nausea/vomiting, diarrhea, stomach pain, and constipation) were ascertained cross-sectionally via a post-deployment survey (median time between deployment end and survey completion 185 days) (N = 4885). Log-binomial regression analyses were employed to calculate prevalence ratios (PRs) and 95 % confidence intervals (CI). Effect modification was evaluated. Results: In adjusted models, responders in the highest (versus lowest) tertile of self-reported degree of skin contact to crude oil were more than twice as likely to report nausea/vomiting (PR=2.45; 95 %CI, 1.85–3.23), diarrhea (PR=2.40; 95 %CI, 2.00–2.88), stomach pain (PR=2.51; 95 %CI, 2.01–3.12), and constipation (PR=2.21; 95 %CI, 1.70–2.89). Tests for trend were statistically significant (p < 0.05). Results were similar for crude oil exposure via inhalation and ingestion. Higher PRs for all symptoms were found with combined crude oil/dispersant exposure than with crude oil exposure alone. Conclusions: These results indicate positive associations between self-reported crude oil and combined crude oil/oil dispersant exposures and acute GI symptoms.
AB - Purpose: Research investigating gastrointestinal (GI) symptoms from oil spill-related exposures is sparse. We evaluated prevalent GI symptoms among U.S. Coast Guard responders deployed to the Deepwater Horizon oil spill cleanup. Methods: Crude oil (via skin contact, inhalation, or ingestion routes), combined crude oil/oil dispersant exposures, other deployment exposures, deployment characteristics, demographics, and acute GI symptoms during deployment (i.e., nausea/vomiting, diarrhea, stomach pain, and constipation) were ascertained cross-sectionally via a post-deployment survey (median time between deployment end and survey completion 185 days) (N = 4885). Log-binomial regression analyses were employed to calculate prevalence ratios (PRs) and 95 % confidence intervals (CI). Effect modification was evaluated. Results: In adjusted models, responders in the highest (versus lowest) tertile of self-reported degree of skin contact to crude oil were more than twice as likely to report nausea/vomiting (PR=2.45; 95 %CI, 1.85–3.23), diarrhea (PR=2.40; 95 %CI, 2.00–2.88), stomach pain (PR=2.51; 95 %CI, 2.01–3.12), and constipation (PR=2.21; 95 %CI, 1.70–2.89). Tests for trend were statistically significant (p < 0.05). Results were similar for crude oil exposure via inhalation and ingestion. Higher PRs for all symptoms were found with combined crude oil/dispersant exposure than with crude oil exposure alone. Conclusions: These results indicate positive associations between self-reported crude oil and combined crude oil/oil dispersant exposures and acute GI symptoms.
KW - Adult
KW - Cross-Sectional Studies
KW - Diarrhea/epidemiology
KW - Environmental Exposure/adverse effects
KW - Female
KW - Gastrointestinal Diseases/epidemiology
KW - Gulf of Mexico
KW - Humans
KW - Male
KW - Middle Aged
KW - Military Personnel/statistics & numerical data
KW - Nausea/epidemiology
KW - Occupational Exposure/adverse effects
KW - Petroleum Pollution/adverse effects
KW - Petroleum/adverse effects
KW - Prevalence
KW - United States/epidemiology
KW - Young Adult
UR - http://www.scopus.com/inward/record.url?scp=85205011911&partnerID=8YFLogxK
U2 - 10.1016/j.annepidem.2024.09.004
DO - 10.1016/j.annepidem.2024.09.004
M3 - Article
C2 - 39326530
AN - SCOPUS:85205011911
SN - 1047-2797
VL - 99
SP - 16
EP - 23
JO - Annals of Epidemiology
JF - Annals of Epidemiology
ER -